|
業務類別
|
-- |
|
業務概覽
|
Shanghai Henlius Biotech Inc is a biopharmaceutical company in China with the vision to offer affordable and biologics for patients with a focus on oncology and autoimmune diseases. The Group is engaged in biopharmaceutical R&D, biopharmaceutical services, and biopharmaceutical production and sales. It operates in Mainland China, Asia Pacific (excluding Mainland China), North America, South America, Oceania, and Europe. The company products include HLX01 Rituximab, HLX02(trastuzumab), and others. |
| 公司地址
| B8 Building, No. 188 Yizhou Road, 11th Floor, Xuhui District, Shanghai, CHN, 200233 |
| 電話號碼
| +86 2133395800 |
| 傳真號碼
| +86 2134611802 |
| 公司網頁
| https://www.henlius.com |
| 員工數量
| 3762 |
| Dr. Jun Zhu |
Director and Chief Executive Officer |
-- |
24/04/2026 |
|
|
| Mr. Wenjie Zhang |
Chairman of the Board |
24/04/2026 |
| Mr. Qiyu Chen |
Director |
24/04/2026 |
| Ms. Xiaohui Guan |
Director |
24/04/2026 |
| Dr. Ruilin Song |
Independent Director |
24/04/2026 |
| Mr. Yuqing Chen |
Director |
24/04/2026 |
| Dr. Jun Zhu |
Director and Chief Executive Officer |
24/04/2026 |
| Dr. Xingli Wang |
Director |
24/04/2026 |
| Mr. Tak Young So |
Independent Director |
24/04/2026 |
| Dr. Lik Yuen Chan |
Independent Director |
24/04/2026 |
| Dr. Yi Liu |
Director |
24/04/2026 |
| Mr. Yihao Zhang |
Independent Director |
24/04/2026 |
|
|
|
|
